Skip to content
  • DOWNLOAD PRESENTATION
  • NASDAQ: MYNZ
Main Menu
  • Home
  • About Us
    • Our Company
    • Our Business
    • Contact Us
  • ColoAlert
  • Investors
  • Clinical Evidence
  • News
  • Careers
NEWS ALERTS
  • Home
  • About Us
    • Our Company
    • Our Business
    • Contact Us
  • ColoAlert
  • Investors
  • Clinical Evidence
  • News
  • Careers
NEWS ALERTS

Day: May 17, 2022

Mainz Biomed to Participate in H.C. Wainwright Global Investment Conference and Equity Forum German Spring Conference

BERKELEY, US – MAINZ, Germany – May 17, 2022 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that members of its executive team will be participating in two notable investor conferences in May, 2022, the H.C. Wainwright Global Investment […]

DOWNLOAD PRESENTATION
  • +49 (0) 6131 / 265140
  • Visit LinkedIn
  • Visit Twitter
  • Visit Facebook
  • +49 (0) 6131 / 265140
  • Visit LinkedIn
  • Visit Twitter
  • Visit Facebook

SITE MENU

Main Menu
  • Home
  • About Us
    • Our Company
    • Our Business
    • Contact Us
  • ColoAlert
  • Investors
  • Clinical Evidence
  • News
  • Careers
Main Menu
  • Home
  • About Us
    • Our Company
    • Our Business
    • Contact Us
  • ColoAlert
  • Investors
  • Clinical Evidence
  • News
  • Careers
VISIT OUR LEGAL HUB

News Alerts Signup

This field is for validation purposes and should be left unchanged.

© 2025 MAINZ BIOMED N.V. ALL RIGHTS RESERVED.

NASDAQ: MYNZ

NASDAQ: MYNZ

  • PRIVACY POLICY (EN)
  • PRIVACY POLICY (DE)
  • DISCLAIMER
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}